midazolam has been researched along with gw 4064 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bass, JY; Caravella, JA; Chen, L; Creech, KL; Deaton, DN; Madauss, KP; Marr, HB; McFadyen, RB; Miller, AB; Mills, WY; Navas, F; Parks, DJ; Smalley, TL; Spearing, PK; Todd, D; Williams, SP; Wisely, GB | 1 |
Ding, X; Fang, C; Jia, K; Zhang, P; Zhang, QY; Zhou, X | 1 |
2 other study(ies) available for midazolam and gw 4064
Article | Year |
---|---|
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.
Topics: Animals; Binding Sites; Blood Glucose; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Dogs; Fluorescence Resonance Energy Transfer; Humans; Isoxazoles; Ligands; Mice; Molecular Conformation; Naphthalenes; Protein Structure, Tertiary; Quinolines; Rats; Receptors, Cytoplasmic and Nuclear; Weight Gain | 2011 |
Dietary regulation of mouse intestinal P450 expression and drug metabolism.
Topics: Animal Feed; Animals; Bile Acids and Salts; Biotransformation; Cytochrome P-450 Enzyme System; Diet; Female; Hydroxylation; Intestines; Isoenzymes; Isoxazoles; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microsomes, Liver; Midazolam; NADPH-Ferrihemoprotein Reductase; Receptors, Cytoplasmic and Nuclear; Substrate Specificity | 2013 |